Pharmaceutical composition for treating alcohol dependency
OwnerPhilippe BERNARD, Fabrice TROVEROinventors
Life of this patent
Estimating the term…
Abstract
Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.
Claims12
A pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients:
- a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine;
- and
- a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from alfuzosin, terazosin and tamsulosin.
(canceled)
A pharmaceutical product containing:
- a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine;
- and
- a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from alfuzosin, terazosin and tamsulosin;
- as a combination product for simultaneous, separate or spread over time administration for treating alcohol dependence in humans.
A method for treating for treating alcohol dependence in humans comprising administering to a patient in need thereof a pharmaceutical composition comprising only two active ingredients, a first of the active ingredients is a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine;
- and a second of the active ingredients is a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from alfuzosin, terazosin and tamsulosin.
Dependencies are inferred from the claim text.